Clinical Trial Update: Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating endocrine therapy with or without abemaciclib (LY2835219) after breast cancer surgery has posted results and the study is currently not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Abemaciclib (abemaciclib)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2021-04-09